Description

Butanenitrile, 4-[[5-(4-Pyridinyl)-1,3,4-oxadiazol-2-yl]thio]- (9Ci) is a specialized organic compound featuring a unique molecular architecture that combines a butanenitrile backbone with a substituted 1,3,4-oxadiazole heterocycle. This structure makes it a valuable high-purity chemical intermediate for advanced research and development, particularly in the synthesis of novel active pharmaceutical ingredients (APIs) and agrochemicals. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents and crop protection solutions.

Application

• Pharmaceutical Intermediate: A key building block in the research and synthesis of novel drug candidates, particularly those targeting neurological or oncological pathways.
• Agrochemical Research: Used in developing next-generation herbicides, fungicides, or insecticides due to its heterocyclic bioactive core.
• Material Science Precursor: Serves as a monomer or functionalization agent in the creation of advanced polymers with specific electronic or optical properties.
• Ligand Synthesis: Employed in organometallic chemistry for the preparation of complex ligands used in catalysis.
• Bioconjugation Chemistry: Potential use in creating linkers for antibody-drug conjugates (ADCs) or other biopharmaceutical constructs.
• Academic & Industrial R&D: A critical reagent for exploratory chemistry in universities and corporate research centers focusing on heterocyclic chemistry.

Basic Information

Product Name	Butanenitrile, 4-[[5-(4-Pyridinyl)-1,3,4-oxadiazol-2-yl]thio]- (9Ci)
CAS No.	604740-19-4
Molecular Formula	C11H10N4OS
Molecular Weight	246.29 g/mol
Synonyms	4-[[5-(4-Pyridinyl)-1,3,4-oxadiazol-2-yl]thio]butanenitrile; 4-((5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)butanenitrile; Butanenitrile, 4-((5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl)thio)-; 4-(5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-ylthio)butyronitrile; CAS 604740-19-4
EINECS	Contact for details

Quality Control

Our production of Butanenitrile, 4-[[5-(4-Pyridinyl)-1,3,4-oxadiazol-2-yl]thio]- (9Ci) adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical characterization, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and lot-to-lot consistency. We provide detailed Certificates of Analysis (COA) with every shipment, documenting all critical specifications. Our quality system is designed to support cGMP-compliant applications in pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from heat, sparks, and open flame. Due to its light-sensitive nature, handling and storage should minimize exposure to direct light.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.